U2Bio Co., Ltd. (KOSDAQ:221800)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,140.00
-350.00 (-6.38%)
At close: Dec 5, 2025
78.78%
Market Cap 69.62B
Revenue (ttm) 25.59B
Net Income (ttm) -2.99B
Shares Out 13.54M
EPS (ttm) -265.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 529,287
Average Volume 4,858,023
Open 5,510.00
Previous Close 5,490.00
Day's Range 5,110.00 - 5,570.00
52-Week Range 2,370.00 - 7,900.00
Beta -0.20
RSI 48.50
Earnings Date n/a

About U2Bio

U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers clinical laboratory test services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical Laboratories
Founded 2009
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 221800
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.